Mundipharma Pharmaceuticals S.R.L.
- H02 - Corticosteroides para uso sistémico
- LODOTRA modified-release tablet 1 mg
- LODOTRA modified-release tablet 2 mg
- LODOTRA modified-release tablet 5 mg
- N02 - Analgésicos
- OXYCONTIN prolonged-release tablet 10 mg
- OXYCONTIN prolonged-release tablet 20 mg
- OXYCONTIN prolonged-release tablet 40 mg
- OXYCONTIN prolonged-release tablet 5 mg
- OXYCONTIN prolonged-release tablet 80 mg
- TARGIN prolonged-release tablet 10 mg+5 mg
- TARGIN prolonged-release tablet 15 mg+7.5 mg
- TARGIN prolonged-release tablet 2.5 mg+1.25 mg
- TARGIN prolonged-release tablet 20 mg+10 mg
- TARGIN prolonged-release tablet 30 mg+15 mg
- TARGIN prolonged-release tablet 40 mg+20 mg
- TARGIN prolonged-release tablet 5 mg+2.5 mg
- R03 - Agentes contra padecimientos obstructivos de las vías respiratorias
- ABRIFF pressurised inhalation, suspension 10 µg/dose+250 µg/dose
- ABRIFF pressurised inhalation, suspension 5 µg/dose+125 µg/dose
- ABRIFF pressurised inhalation, suspension 5 µg/dose+50 µg/dose
- AFFERA K-HALER pressurised inhalation, suspension 125 µg/dose+5 µg/dose
- AFFERA K-HALER pressurised inhalation, suspension 50 µg/dose+5 µg/dose
- AFFERA pressurised inhalation, suspension 125 µg/dose+5 µg/dose
- AFFERA pressurised inhalation, suspension 250 µg/dose+10 µg/dose
- AFFERA pressurised inhalation, suspension 50 µg/dose+5 µg/dose
- FLUTIFORMO pressurised inhalation, suspension 10 µg/dose+250 µg/dose
- FLUTIFORMO pressurised inhalation, suspension 5 µg/dose+125 µg/dose
- FLUTIFORMO pressurised inhalation, suspension 5 µg/dose+50 µg/dose